. 1999 Apr;90(4):393–398. doi: 10.1111/j.1349-7006.1999.tb00760.x
Mizuki Onozawa
1,2, Toshihiko Kawamori
1, Masaki Baba
1, Kazunori Fukuda
1, Toshiya Toda
3, Hidetaka Sato
4, Mikinobu Ohtani
2, Hideyuki Akaza
2, Takashi Sugimura
1, Keiji Wakabayashi
1,✉
PMCID: PMC5926079PMID: 10363576
Abstract
Several epidemiological studies have suggested an inverse association between the risk of prostate cancer and intake of soybeans and their products. In vitro data pointing to possible anti‐carcinogenic properties of the soybean isoflavone, genistein, led us to investigate the chemopreventive potential of soybean isoflavones in a rat carcinogenesis model induced by 3,2′‐dimethyl‐4‐aminobi‐phenyl (DMAB) and testosterone propionate (TP). Animals received DMAB s.c. injections at 2‐week intervals for the first 20 weeks and implanted silicon tubes containing 40 mg of TP, replaced at 6‐week intervals throughout the experiment. The soybean isoflavone mixture consisting of 74% genistein and 21% daidzein was mixed in basal diet (AIN‐76A) at concentrations of 100 and 400 ppm and fed to F344 male rats throughout the experiment. Rats treated with carcinogens and administered isoflavone mixture at 100 and 400 ppm developed adenocarcinomas at incidences of 35% and 29%, respectively, in the prostate and seminal vesicles, whereas the figure was 60% for those maintained on control diet. Feeding of the isoflavone mixture at 100 and 400 ppm significantly inhibited the number of argyrophilic nucleolar organizer regions (AgNORs) in adenocarcinomas of the accessory sex glands as compared to those of rats fed control diet. No influence on the development of neoplastic lesions originating in other organs was noted. The results of this study provide evidence that soybean isoflavones may have potential as chemopreventive agents against carcinogenesis in the prostate.
Keywords: Prostate cancer, Seminal vesicle cancer, Genistein, Isoflavone, Chemoprevention
Full Text
The Full Text of this article is available as a PDF (107.9 KB).
REFERENCES
- 1).Parker,S. L.,Tong,T.,Bolden,S.andWingo,P. A.Cancer statistics, 1997.CA Cancer J. Clin.,47,5–27(1997). [DOI] [PubMed] [Google Scholar]
- 2).Kozlowski,J. M.,Ellis,W. J.andGrayhack,J. T.Advanced prostatic carcinoma. Early versus late endocrine therapy.Urol. Clin. North Am.,18,15–24(1991. ). [PubMed] [Google Scholar]
- 3).McConnell,J. D.Physiologic basis of endocrine therapy for prostatic cancer.Urol. Clin. North Am.,18,1–13(1991. ). [PubMed] [Google Scholar]
- 4).Crawford,E. D.andNabors,W. L.Total androgen ablation: American experience.Urol. Clin. North Am.,18,55–63(1991. ). [PubMed] [Google Scholar]
- 5).Brawley,O. W.andThompson,I. M.Chemoprevention of prostate cancer.Urology,43,594–599(1994. ). [DOI] [PubMed] [Google Scholar]
- 6).Tsukamoto,S.,Akaza,H.,Imada,S.,Koiso,K.,Shirai,T.,Ideyama,Y.andKudo,M.Chemoprevention of rat prostate carcinogenesis by use of finasteride or casodex.J. Natl. Cancer Inst.,87,842–843(1995. ). [DOI] [PubMed] [Google Scholar]
- 7).Tsukamoto,S.,Akaza,H.,Onozawa,M.,Shirai,T.andIdeyama,Y.A five‐alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats.Cancer,82,531–537(1998. ). [DOI] [PubMed] [Google Scholar]
- 8).Wynder,E. L.,Rose,D. P.andCohen,L. A.Nutrition and prostate cancer: a proposal for dietary intervention.Nutr. Cancer,22,1–10(1994. ). [DOI] [PubMed] [Google Scholar]
- 9).Adlercreutz,H.,Honjo,H.,Higashi,A.,Fotsis,T.,Hamalainen,E.,Hasegawa,T.andOkada,H.Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet.Am. J. Clin. Nutr.,54,1093–1100(1991. ). [DOI] [PubMed] [Google Scholar]
- 10).Hawrylewicz,E. J.,Huang,H. H.andBlair,W. H.Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats.J. Nutr.,121,1693–1698(1991. ). [DOI] [PubMed] [Google Scholar]
- 11).Kennedy,A. R.The evidence for soybean products as cancer preventive agents.J. Nutr.,125,733s–743s(1995. ). [DOI] [PubMed] [Google Scholar]
- 12).Messina,M. J.,Persky,V.,Setchell,K. D.andBarnes,S.Soy intake and cancer risk: a review of the in vitro and in vivo data.Nutr. Cancer,21,113–131(1994. ). [DOI] [PubMed] [Google Scholar]
- 13).Akiyama,T.,Ishida,J.,Nakagawa,S.,Ogawara,H.,Watanabe,S.,Itoh,N.,Shibuya,M.andFukami,Y.Genistein, a specific inhibitor of tyrosine‐specific protein kinases.J. Biol. Chem.,262,5592–5595(1987. ). [PubMed] [Google Scholar]
- 14).Linassier,C.,Pierre,M.,LePecq,J.‐B.andPierre,J.Mechanisms of action in NIH‐3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity.Biochem. Pharmacol.,39,187–193(1990. ). [DOI] [PubMed] [Google Scholar]
- 15).Markovits,J.,Linassier,C.,Fosse,P.,Couprie,J.,Pierre,J.,Jacquemin‐Sablon,A.,Saucier,J. M.,LePecq,J. B.andLarsen,A. K.Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.Cancer Res.,49,5111–5117(1989. ). [PubMed] [Google Scholar]
- 16).Fotsis,T.,Pepper,M.,Adlercreutz,H.,Hase,T.,Montesano,R.andSchweigerer,L.Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis.J. Nutr.,125,790s–797s(1995. ). [DOI] [PubMed] [Google Scholar]
- 17).Onozawa,M.,Fukuda,K.,Ohtani,M.,Akaza,H.,Sugimura,T.andWakabayashi,K.Effects of soybean isoflavones on cell growth and apoptosis of the human pro‐static cancer cell line LNCaP.Jpn. J. Clin. Oncol.,28,360–363(1998. ). [DOI] [PubMed] [Google Scholar]
- 18).Deschenes,J.andWeidner,N.Nucleolar organizer regions (NOR) in hyperplastic and neoplastic prostate disease.Am. J. Surg. Pathol.,14,1148–1155(1990. ). [DOI] [PubMed] [Google Scholar]
- 19).Eskelinen,M.,Lipponen,P.andSyrjanen,K.Nucleolar organiser regions (AgNORs) related to histopathological characteristics and survival in prostatic adenocarcinoma.Anticancer Res.,12,1635–1640(1992. ). [PubMed] [Google Scholar]
- 20).Masai,M.,Abe,K.,Akimoto,S.,Yatani,R.andShimazaki,J.Argyrophilic nucleolar organizer regions in benign hyperplastic and cancerous human prostates.Prostate,20,1–13(1992. ). [DOI] [PubMed] [Google Scholar]
- 21).Chiusa,L.,Galliano,D.,Formiconi,A.,Di‐Primio,O.andPich,A.High and low risk prostate carcinoma determined by histologic grade and proliferative activity.Cancer,79,1956–1963(1997. ). [DOI] [PubMed] [Google Scholar]
- 22).Shirai,T.,Imaida,K.,Iwasaki,S.,Mori,T.,Tada,M.andIto,N.Sequential observation of rat prostate lesion development induced by 3,2′‐dimethyl‐4‐aminobiphenyl and testosterone.Jpn. J. Cancer Res.,84,20–25(1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23).Ito,N.andShirai,T.Tumours of the accessory male sex organs.In“Pathology of Tumours in Laboratory Animals”,ed.Turusov V. S.andMohr U.,pp.421–443(1990. ).IARC Sci. Publ.,Lyon. [PubMed] [Google Scholar]
- 24).Tanaka,T.,Takeuchi,T.,Nishikawa,A.,Takami,T.andMori,H.Nucleolar organizer regions in hepatocarcinogenesis induced by N‐2‐fluorenylacetamide in rats: comparison with bromodeoxyuridine immunohistochemistry.Jpn. J. Cancer Res.,80,1047–1051(1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25).Lamartiniere,C. A.,Moore,J. B.,Brown,N. M.,Thompson,R.,Hardin,M. J.andBarnes,S.Genistein suppresses mammary cancer in rats.Carcinogenesis,16,2833–2840(1995. ). [DOI] [PubMed] [Google Scholar]
- 26).Kawamori,T.,Tanaka,T.,Ohnishi,M.,Hirose,Y.,Nakamura,Y.,Satoh,K.,Hara,A.andMori,H.Chemo‐prevention of azoxymethane‐induced colon carcinogenesis by dietary feeding of s‐methyl methane thiosulfonate in male F344 rats.Cancer Res.,55,4053–4058(1995. ). [PubMed] [Google Scholar]
- 27).Kakeji,Y.,Maehara,Y.,Tomoda,M.,Kabashima,A.,Ohmori,M.,Oda,S.,Ohno,S.andSugimachi,K.Long‐term survival of patients with stage IV gastric carcinoma.Cancer,82,2307–2311(1998. ). [DOI] [PubMed] [Google Scholar]
